Tirzepatide is a once-weekly injectable medication used in both type 2 diabetes management (as Mounjaro) and chronic weight management (as Zepbound). It works by gradually increasing insulin response, slowing gastric emptying, and reducing appetite. Because of its strong gastrointestinal effects early in treatment, dosing follows a slow, step-up titration schedule rather than starting at a full therapeutic dose.
This article breaks down the standard tirzepatide dosage chart, including starting dose, escalation timeline, maintenance doses, and maximum limits.
🧪 Standard Tirzepatide Dosage Chart (Weekly Schedule)
The FDA-approved dosing schedule is the same for both Mounjaro and Zepbound:
| Phase | Weeks | Dose (Once Weekly) | Purpose |
|---|---|---|---|
| Starter | Weeks 1–4 | 2.5 mg | Body adjustment (not therapeutic dose) |
| Step 1 | Weeks 5–8 | 5 mg | First effective dose |
| Step 2 | Weeks 9–12 | 7.5 mg | Increased metabolic control |
| Step 3 | Weeks 13–16 | 10 mg | Stronger appetite and glucose control |
| Step 4 | Weeks 17–20 | 12.5 mg | Near-max response level |
| Max / Maintenance | Week 21+ | 15 mg | Maximum approved dose |
This step-up pattern is typically done every 4 weeks, depending on tolerance and clinical response.
📈 Key Principles of Tirzepatide Dosing
1. Starting dose is NOT for weight loss or full control
- 2.5 mg is used only to reduce side effects like nausea and bloating
- Most clinical benefits begin at 5 mg and above
2. Slow titration reduces side effects
- Dose increases every 4 weeks help the body adapt
- Faster increases may increase gastrointestinal symptoms
3. Not everyone reaches the maximum dose
Many patients remain on:
- 5 mg (mild responders)
- 10 mg (moderate responders)
- 15 mg (maximum response)
Doctors often choose the lowest effective dose, not necessarily the highest.
⚖️ Maintenance Dose Options
Clinical guidelines and real-world prescribing show that maintenance dosing is flexible:
- 5 mg weekly → early responders or sensitive patients
- 10 mg weekly → common long-term balance dose
- 15 mg weekly → maximum efficacy dose
Some patients never need to escalate beyond 5–10 mg if results are stable.
⛔ Maximum Dose
- The maximum approved dose is 15 mg once weekly
- Exceeding this is not recommended under current prescribing guidelines
📊 Typical 20-Week Titration Timeline (Simplified)
- Month 1 → 2.5 mg
- Month 2 → 5 mg
- Month 3 → 7.5 mg
- Month 4 → 10 mg
- Month 5 → 12.5 mg
- Month 6 → 15 mg
Total time to reach maximum dose: ~20 weeks
💡 Important Clinical Notes
- Dose increases are typically done only if the current dose is tolerated
- If side effects occur, clinicians may:
- Stay longer at the same dose
- Reduce dose temporarily
- There is no requirement that every patient must reach 15 mg
⚠️ Safety Reminder
Tirzepatide is a prescription medication. Dosing should always be guided by a healthcare professional based on:
- Blood sugar response (for diabetes)
- Weight loss progress (for obesity treatment)
- Side effect tolerance
- Medical history
🧾 Summary
The tirzepatide dosage chart follows a structured 2.5 mg → 15 mg escalation every 4 weeks, with flexibility based on individual response. The goal is not maximum dose, but maximum benefit with minimum side effects.